Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

E5D86770B2C7618487258257005CC3F3 Hearing Summary


Date Mar 21, 2018      
Location SCR 354

HB18-1148 - Referred to the Committee of the Whole

10:53:16 AM  

Senator Crowder, bill sponsor, presented House Bill 18-1148.  The bill prohibits health insurers from requiring that a person undergo step therapy prior to receiving a federally approved drug for stage four metastatic cancer if the use of the drug is consistent with best practices for treatment of the cancer.  Step therapy is a protocol under which a health insurer first requires that a certain drug or sequence of drugs be tried before coverage is provided for the drug that was recommended by a health care provider.  Under current law, health insurers are only prohibited from requiring step therapy in instances where a prescription drug mandated under a step therapy protocol has previously been tried by the covered person but was discontinued due to lack of efficacy or adverse event.

10:55:54 AM  
Diane Robinson, Colorado Senior Lobby, testified in support of the bill.
10:58:25 AM  
Senator Crowder distributed a handout to the committee [Attachment A] and read a letter from a cancer patient.
11:02:45 AM  
Committee discussion followed.

11:16:21 AM
Motion Refer House Bill 18-1148 to the Committee of the Whole.
Moved Crowder
Aguilar Yes
Crowder Yes
Kefalas Yes
Martinez Humenik Yes
Smallwood No
Final YES: 4   NO: 1   EXC: 0   ABS:  0   FINAL ACTION:  PASS

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details